Gene May Hold Key To Treating Life-Threatening Cholesterol

May 28, 1998

DALLAS, Texas, May 29, 1998 -- Findings from a study, in which a gene that speeds cholesterol metabolism was turned off, will help scientists develop better drugs for controlling life-threatening levels of the substance, researchers at UT Southwestern Medical Center at Dallas reported in the May 29 issue of Cell.

The gene that was turned off expresses liver X receptor, or LXR-alpha, a protein molecule found primarily in the nucleus of liver cells. The researchers engineered mice that lacked LXR-alpha, then fed them diets high in cholesterol. Without the receptor, the cholesterol levels in the mice rose so high it destroyed liver function. In humans, excessive amounts of cholesterol cause arteriosclerosis leading to heart attacks.

"Without LXR-alpha the animals completely lose their ability to deal with dietary cholesterol," said Dr. David Mangelsdorf, senior author of the paper, associate professor of pharmacology and Howard Hughes Medical Institute (HHMI) investigator. "We believe that this may work the same way in humans because the receptor is almost identical to the one in mice."

In normal animals, a hormone associated with cholesterol tells LXR-alpha to signal enzymes to increase the rate of cholesterol conversion to bile acid. Without LXR-alpha, this process doesn't occur, and cholesterol accumulates in the liver.

Mangelsdorf said scientists have found a perfect drug target in LXR-alpha. He plans to look for ways to biochemically design hormonal ligands that can speed metabolism and reduce dietary cholesterol levels in humans. Screening for mutations in LXR-alpha also may help identify inherited defects in cholesterol metabolism.

"This study suggests that we can develop an excellent drug to treat high levels of dietary cholesterol by altering the molecules that bind with LXR-alpha. Now we will use different levels of dietary cholesterol in longer-term studies to see if it causes atherogenesis in these genetically engineered mice," he said. "A key question is whether bile-acid synthesis is increased in humans through the same biochemical pathway as it is in mice."

The other researchers involved in the study were: Dr. Daniel Peet, HHMI associate; Dr. Stephen Turley, professor of internal medicine; Wenzhen Ma, HHMI research technician; Bethany Janowski, student research assistant in pharmacology; Dr. Jean-Marc Lobaccaro, HHMI associate; and Dr. Robert Hammer, associate professor of biochemistry and HHMI senior associate.

The Robert A. Welch Foundation, the Moss Heart Fund and the U.S. Public Health Service funded the study.

UT Southwestern Medical Center

Related Cholesterol Articles from Brightsurf:

Cholesterol's effects on cellular membranes
The findings have far-reaching implications in the general understanding of disease, the design of drug delivery methods, and many other biological applications that require specific assumptions about the role of cholesterol in cell membranes.

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

Microbes might manage your cholesterol
Researchers discover a link between human blood cholesterol levels and a gene in the microbiome that could one day help people manage their cholesterol through diet, probiotics, or entirely new types of treatment.

Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov.

Rethinking how cholesterol is integrated into cells
Cholesterol is best known in connection with cardiovascular disease, but cholesterol is also vital for many fundamental processes in the body.

Seed oils are best for LDL cholesterol
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.

Cholesterol leash: Key tethering protein found to transport cellular cholesterol
Cholesterol is an essential component of living organisms, but the mechanisms that transport cholesterol inside the cell are poorly understood.

New way to treat cholesterol may be on the horizon
A breakthrough discovery by scientists at Houston Methodist Research Institute could change the way we treat cholesterol.

How low should LDL cholesterol go?
New analysis shows that in a high-risk population, achieving ultra-low LDL cholesterol levels, down to <10 mg/dL, safely results in additional lowering of risk of cardiovascular events.

Does boosting 'good' cholesterol really improve your health?
A new review addresses the mysteries behind 'good' HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients.

Read More: Cholesterol News and Cholesterol Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to